COVID-19 Resource Center

COVID-19 Resource Center

Disclosures: Levitz reports no relevant financial disclosures.
April 27, 2021
1 min watch
Save

VIDEO: SARs-CoV-2 reinfection in liver transplant patients due to lack of immunoresponse

Disclosures: Levitz reports no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this video exclusive, Stuart M. Levtiz, MD, discussed the implications he and his team discovered after the case-study of a liver transplant recipient who was reinfected with SARS-CoV-2.

Levitz, professor of medicine at the University of Massachusetts Medical School, said it was not surprising that an immunosuppressed liver transplant recipient who could be reinfected from SARs-CoV-2 due to lack of immunoresponse.

“The patient may not mount a great immunoresponse to infection and therefor be reinfected,” Levitz said. “It has a lot of implications in terms of infection control, cautions and what the patient should be doing in terms of continuing masking and being cautious.”

He said patients who are immunocompromised due to a sold organ transplant many times do not mount a great response to vaccines.